Lp(a)] has emerged as a major, genetically determined risk factor in atherosclerotic cardiovascular disease (ASCVD) and ...

A panel discussion titled “Elevated Lipoprotein(a): Raise Your Game and Lower Your (Risk) Score?” presented at the American Heart Association (AHA) Scientific Sessions 2023, which convened in ...

Some cardiologists say that certain people — such as those with a family history of premature heart disease — would benefit from having their lipoprotein(a) level checked, as well as their HDL and LDL ...

The study data support efforts to extend strategies for the primary prevention of atherosclerotic events beyond traditional 10-year estimates of risk. HealthDay News — A single combined measure of ...

In a recent study published in the journal Current Medical Research and Opinion, researchers report that high lipoprotein(a) levels were linked to repeated coronary heart disease events in older ...

A recent study published in the Virology Journal has highlighted the significance of high-density lipoprotein (HDL) in coronavirus disease 2019 (COVID-19) pathogenesis and outcome. A severely low ...

Elevated lipoprotein (a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting hepa ...

This is a preview. Log in through your library . Abstract Studies in cultured fibroblasts from patients with the clinical syndrome of homozygous familial hypercholesterolemia have disclosed two ...

Following these positive 36-week results, Silence Therapeutics plans to announce 48-week results of the ongoing ALPACAR-360 study in Q2 of 2024. Silence Therapeutics has released promising findings ...